Cholesfytol NG

Cholefytol NG New Generation: a product with an innovative mode of action to regulate the cholesterol of patients*!
From a scientific point of view the Amla present in Cholesfytol NG regulates the expression of PCSK-91 to increase the activity of LDL receptors. Monacolin K acts on HMG CoA-reductase to act on endogenous cholesterol production. Hydroxytyrosol reduces the oxidation of LDL2 and improves endothelial function3-4. Finally, Walnut  leave  helps  to  control  the  lipid  metabolism. All these components are clinically studied and guarantee excellent muscle tolerance.

* Walnut  leave  helps  to  control  the  lipid  metabolism  (cholesterol  and triglyceride). The synergy of components ensures a scientifically documented action on lipid metabolism.
1 Variya BC et al. Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety. BIOMED PHARMACOTHER. 2018;108:1274–81
2 Verhoeven V et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome? A double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015;15:52
3 Moreno-Luna R et al. Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension. AM J HYPERTENS. 2012;25(12):1299-304
4 Lockyer S et al. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial. EUR J NUTR. 2017;56(4)1421-32